[Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature]

Fortschr Med. 1996 Mar 20;114(8):85-7.
[Article in German]

Abstract

The aim of this systematic review was to evaluate the effectiveness of ginkgo biloba in the treatment of intermittent claudication. A Medline-search identified ten controlled trials on the subject. These were heterogeneous in all respects and, with only few exceptions, of poor methodological quality. All the studies implied that ginkgo biloba is an effective therapy for intermittent claudication. This hypothesis should be confirmed in further trials employing meticulous methodology. Furthermore it would also be important to determine whether oral ginkgo biloba can be usefully combined with walking exercise.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Clinical Trials as Topic
  • Diterpenes*
  • Double-Blind Method
  • Fibrinolytic Agents / therapeutic use*
  • Ginkgolides
  • Humans
  • Intermittent Claudication / drug therapy*
  • Lactones / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Diterpenes
  • Fibrinolytic Agents
  • Ginkgolides
  • Lactones
  • ginkgolide B